Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M604550200 on June 5, 2006

J. Biol. Chem., Vol. 281, Issue 32, 23254-23263, August 11, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/32/23254    most recent
M604550200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, R. J.
Right arrow Articles by Craik, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, R. J.
Right arrow Articles by Craik, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Synthesis, Structural Characterization, and Receptor Specificity of the {alpha}-Conotoxin Vc1.1*

Richard J. Clark{ddagger}1, Harald Fischer§1, Simon T. Nevin§1, David J. Adams§, and David J. Craik{ddagger}2

From the {ddagger}Institute for Molecular Bioscience and §School of Biomedical Sciences, University of Queensland, Brisbane, Queensland 4072, Australia

The {alpha}-conotoxin Vc1.1 is a small disulfide-bonded peptide currently in development as a treatment for neuropathic pain. This study describes the synthesis, determination of the disulfide connectivity, and the determination of the three-dimensional structure of Vc1.1 using NMR spectroscopy. Vc1.1 was shown to inhibit nicotine-evoked membrane currents in isolated bovine chromaffin cells in a concentration-dependent manner and preferentially targets peripheral nicotinic acetylcholine receptor (nAChR) subtypes over central subtypes. Specifically, Vc1.1 is selective for {alpha}3-containing nAChR subtypes. The three-dimensional structure of Vc1.1 comprises a small {alpha}-helix spanning residues Pro6 to Asp11 and is braced by the I-III, II-IV disulfide connectivity seen in other {alpha}-conotoxins. A comparison of the structure of Vc1.1 with other {alpha}-conotoxins, taken together with nAChR selectivity data, suggests that the conserved proline at position 6 is important for binding, whereas a number of residues in the C-terminal portion of the peptide contribute toward the selectivity. The structure reported here should open new opportunities for further development of Vc1.1 or analogues as analgesic agents.


Received for publication, May 12, 2006

The atomic coordinates and structure factors (code 2H8S) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* This work was supported in part by funding from the Australian Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 These authors contributed equally to this work.

2 An Australian Research Council Professorial Fellow. To whom correspondence should be addressed. Tel.: 61-7-3346-2019; Fax: 61-7-3346-2029; E-mail: d.craik{at}imb.uq.edu.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Armishaw, A. A. Jensen, T. Balle, R. J. Clark, K. Harpsoe, C. Skonberg, T. Liljefors, and K. Stromgaard
Rational Design of {alpha}-Conotoxin Analogues Targeting {alpha}7 Nicotinic Acetylcholine Receptors: IMPROVED ANTAGONISTIC ACTIVITY BY INCORPORATION OF PROLINE DERIVATIVES
J. Biol. Chem., April 3, 2009; 284(14): 9498 - 9512.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Callaghan, A. Haythornthwaite, G. Berecki, R. J. Clark, D. J. Craik, and D. J. Adams
Analgesic {alpha}-Conotoxins Vc1.1 and Rg1A Inhibit N-Type Calcium Channels in Rat Sensory Neurons via GABAB Receptor Activation
J. Neurosci., October 22, 2008; 28(43): 10943 - 10951.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. T. Nevin, R. J. Clark, H. Klimis, M. J. Christie, D. J. Craik, and D. J. Adams
Are {alpha}9{alpha}10 Nicotinic Acetylcholine Receptors a Pain Target for {alpha}-Conotoxins?
Mol. Pharmacol., December 1, 2007; 72(6): 1406 - 1410.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Vincler, S. Wittenauer, R. Parker, M. Ellison, B. M. Olivera, and J. M. McIntosh
Molecular mechanism for analgesia involving specific antagonism of {alpha}9{alpha}10 nicotinic acetylcholine receptors
PNAS, November 21, 2006; 103(47): 17880 - 17884.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement